9NTN image
Deposition Date 2025-03-18
Release Date 2025-05-07
Last Version Date 2025-10-08
Entry Detail
PDB ID:
9NTN
Title:
Structure of Cap10-CdnD complex containing NDG modification
Biological Source:
Source Organism:
Hyphomicrobiales (Taxon ID: 356)
Method Details:
Experimental Method:
Resolution:
2.43 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Cap10
Chain IDs:A, B
Chain Length:332
Number of Molecules:2
Biological Source:Hyphomicrobiales
Polymer Type:polypeptide(L)
Molecule:CdnD
Chain IDs:C (auth: G), D (auth: H)
Chain Length:320
Number of Molecules:2
Biological Source:Hyphomicrobiales
Primary Citation
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity.
Science 389 1347 1352 (2025)
PMID: 40997174 DOI: 10.1126/science.adx6053

Abstact

7-Deazapurines are nucleobase analogs essential for nucleic acid modifications in nearly all cellular life. In this study, we discovered a role for 7-deazapurines in protein modification within type IV cyclic oligonucleotide-based antiviral signaling system (CBASS) antiphage defense and defined functions for CBASS ancillary proteins Cap9 and Cap10 in nucleobase-protein conjugation. A structure of Cap10 revealed a transfer RNA transglycosylase family enzyme remodeled to bind a partner cGAS/DncV-like nucleotidyltransferase that is modified with an N-terminal 7-amido-7-deazaguanine (NDG) nucleobase. A structure of Cap9 explained how this QueC-like enzyme co-opts a 7-deazapurine biosynthetic reaction to install NDG. We show that Cap9, Cap10, and protein deazaguanylation are essential for host defense against phage infection. Our results define a 7-deazapurine protein modification and explain how nucleobase biosynthetic machinery has been repurposed for antiviral immunity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures